GovChime
UEI: LB3AM53JKK33 • CAGE: 5UEH4

SEDIA BIOSCIENCES CORPORATION (OR)

DBA: SEDIA BIOSCIENCES CORP

Registration and award facts

SAM.gov registration as of

Net obligations since FY2011
$1.35M
$1,347,733under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
18
with positive net obligations
Latest action
Sep 15, 2023
SAM.gov registration
Active
Registration expiration date Aug 12, 2027

Registration

Doing business as
SEDIA BIOSCIENCES CORP
Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jan 26, 2009 (17 years)
Location
Beaverton, OR
State of incorporation
Delaware
Purpose of registration
All Awards
Website
sediabio.com

† FY2026 obligations (provisional; DoD awards signed after Jul 24, 2026 are not yet public).

All federal contractors in OregonHow these figures are built

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI LB3AM53JKK33. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2011. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2023: $4,313
  • FY2020: $119,155
  • FY2019: $149,825
  • FY2018: $190,010
  • FY2017: $133,920
  • FY2016: -$15,950 (de-obligation)
  • FY2014: $102,700
  • FY2013: $83,760
Show all 10 years
  • FY2012: $320,160
  • FY2011: $259,840

Total across 10 fiscal years: $1,347,733

Net de-obligation in that fiscal year (obligations withdrawn).

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • 6550In vitro diagnostic substances, reagents, test kits and sets$751,608, 55.8%
  • 6640Laboratory equipment and supplies$540,575, 40.1%
  • AJ95R&d-other sciences-opsy dev$31,240, 2.3%
  • 6515Medical and surgical instruments, equipment, and supplies$15,860, 1.2%
  • 6505Drugs and biologicals$8,450, 0.6%

Capabilities

SBA certifications

No certification in the SBA profile data.

Product and service codes (PSC)

  • AN12R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
  • 6505DRUGS AND BIOLOGICALS
  • AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT)
  • AN11R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
  • 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Federal Capability Statement

Sedia is a leader in the development of novel in-vitro diagnostic assays using alternative fluid specimens (e.g. oral fluid, urine) for disease detection. Sedia is also the leading manufacturer of HIV incidence type assays.

Capabilities & Services

Manufacture
research
development
in-vitro
diagnostic
incidence
tests
assays
rapid
oral
saliva
urine
blood
surveillance
BED
Avidity
recency
HIV
DNA
sample
collection
IVD

Contracts

Latest awards and orders

  1. 75D30123P17526Purchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  2. 75D30118P03105Purchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  3. 75D30120P09529Purchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  4. 75D30119P05114Purchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  5. 75D30118P00792Purchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  6. HHSD2002017M94999PPurchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  7. HHSD2002017M94995PPurchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  8. HHSD2002017M94760PPurchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  9. HHSD2002012M50346PPurchase orderDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
  10. HHSD200201251323CDefinitive contractDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for SEDIA BIOSCIENCES CORPORATION lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

9590 SW GEMINI DR

STE 120

BEAVERTON, OR, 97008

USA

Mailing Address

9590 SW GEMINI DR

STE 120

BEAVERTON, OR, 97008

USA

Government Business Contact

Roger I Gale

Mr.

SEDIA BIOSCIENCES CORP.

BEAVERTON, OR, 97008

USA

Electronic Business Contact

Roger I Gale

Mr.

SEDIA BIOSCIENCES CORP.

BEAVERTON, OR, 97008

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

SEDIA BIOSCIENCES CORPORATION has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires August 12, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization

Registration Details

Source: SAM.gov

Initial Registration

Aug 12, 2026

Last Update

Aug 13, 2026

Registration Activation

Active — Aug 13, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

01

Other contractors in Oregon with primary NAICS 325413